| Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and Consensus Molecular Subtypes JM Loree, AAL Pereira, M Lam, AN Willauer, K Raghav, A Dasari, ... Clinical Cancer Research 24 (5), 1062-1072, 2018 | 314 | 2018 |
| Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and Consensus Molecular Subtypes KS Loree JM, Pereira AA, Lam M, Willauer AN, Raghav K, Dasari A, Morris VK ... Clin Cancer Res, 2017 | 314* | 2017 |
| Clinical and molecular characterization of early‐onset colorectal cancer AN Willauer, Y Liu, AAL Pereira, M Lam, JS Morris, KPS Raghav, ... Cancer 125 (12), 2002-2010, 2019 | 275 | 2019 |
| Genomic landscape of cell-free DNA in patients with colorectal cancer JH Strickler, JM Loree, LG Ahronian, AR Parikh, D Niedzwiecki, ... Cancer discovery 8 (2), 164-173, 2018 | 253 | 2018 |
| Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge CM Parseghian, JM Loree, VK Morris, X Liu, KK Clifton, S Napolitano, ... Annals of Oncology 30 (2), 243-249, 2019 | 196 | 2019 |
| Gonadotropin-releasing hormone agonists for ovarian function preservation in premenopausal women undergoing chemotherapy for early-stage breast cancer: a systematic review and … RR Munhoz, AAL Pereira, AD Sasse, PM Hoff, TA Traina, CA Hudis, ... JAMA oncology 2 (1), 65-73, 2016 | 149 | 2016 |
| Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and … RR Munhoz, AAL Pereira, AD Sasse, PM Hoff, TA Traina, CA Hudis, ... JAMA oncology 2 (1), 65-73, 2016 | 149 | 2016 |
| Association between KRAS mutation and lung metastasis in advanced colorectal cancer AAL Pereira, JFM Rego, V Morris, MJ Overman, C Eng, CR Garrett, ... British journal of cancer 112 (3), 424-428, 2015 | 95 | 2015 |
| Association between KRAS mutation and lung metastasis in advanced colorectal cancer AAL Pereira, JFM Rego, V Morris, MJ Overman, C Eng, CR Garrett, ... British journal of cancer 112 (3), 424-428, 2015 | 95 | 2015 |
| Refractory carcinoid syndrome: a review of treatment options RP Riechelmann, AA Pereira, JFM Rego, FP Costa Therapeutic advances in medical oncology 9 (2), 127-137, 2017 | 69 | 2017 |
| Targeting the Hedgehog Pathway in Cancer: Current Evidence and Future Perspectives D Girardi, A Barrichello, G Fernandes, A Pereira Cells 8 (2), 153, 2019 | 60 | 2019 |
| Genomic landscape of cell-free DNA in patients with colorectal cancer. Cancer Discov. 2018; 8: 164–173. doi: 10.1158/2159-8290 JH Strickler, JM Loree, LG Ahronian, AR Parikh, D Niedzwiecki, ... CD-17-1009.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 46 | |
| Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics M Khan, JM Loree, SM Advani, J Ning, W Li, AAL Pereira, M Lam, ... Clinical colorectal cancer 17 (4), e699-e709, 2018 | 43 | 2018 |
| Circulating tumor DNA (ctDNA) utilizing a high-sensitivity panel to detect minimal residual disease post liver hepatectomy and predict disease recurrence. MJ Overman, JN Vauthey, TA Aloia, C Conrad, YS Chun, AAL Pereira, ... Journal of Clinical Oncology 35 (15_suppl), 3522-3522, 2017 | 41 | 2017 |
| Clinical impact of adjuvant radiation therapy delay after neoadjuvant chemotherapy in locally advanced breast cancer SB Silva, AAL Pereira, GN Marta, KML de Barros Lima, TB de Freitas, ... The Breast 38, 39-44, 2018 | 26 | 2018 |
| Clinical utility of circulating cell-free DNA in advanced colorectal cancer AAL Pereira, MP Morelli, M Overman, B Kee, D Fogelman, E Vilar, ... PLoS One 12 (8), e0183949, 2017 | 26 | 2017 |
| Immunotherapy and targeted therapy for hepatocellular carcinoma: a literature review and treatment perspectives DM Girardi, JPM Pacífico, FPL Guedes de Amorim, ... Pharmaceuticals 14 (1), 28, 2020 | 23 | 2020 |
| Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay K Clifton, TA Rich, C Parseghian, VM Raymond, A Dasari, AAL Pereira, ... JCO Precision Oncology 3, 1-15, 2019 | 22 | 2019 |
| Anti-EGFR resistant clones decay exponentially after progression: implications for anti-EGFR rechallenge. CM Parseghian, JM Loree, VK Morris, AAL Pereira, E Vilar Sanchez, ... Journal of Clinical Oncology 36 (15_suppl), 3511-3511, 2018 | 22 | 2018 |
| The impact of complete chemotherapy stop on the overall survival of patients with advanced colorectal cancer in first-line setting: A meta-analysis of randomized trials AAL Pereira, JFM Rego, RR Munhoz, PM Hoff, AD Sasse, ... Acta Oncologica 54 (10), 1737-1746, 2015 | 22 | 2015 |
